Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 10/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.64 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6474035 | 1.00 | OPRD1 (0.64) | OPRD1OPRM1OPRK1CTSLCTSB | |
| SCHEMBL30100565 | 0.94 | OPRD1 (0.73) | OPRD1OPRM1OPRK1 | |
| SCHEMBL21010207 | 0.92 | OPRD1 (0.64) | OPRD1OPRM1OPRK1CTSLCTSB | |
| SCHEMBL30637561 | 0.92 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29505897 | 0.92 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30865865 | 0.92 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL17430646 | 0.92 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30637530 | 0.92 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30637587 | 0.92 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30051754 | 0.91 | OPRD1 (0.59) | OPRD1OPRM1OPRK1CTSSMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-1254379-A | Method for producing amidated peptides by using fusion proteins | PPL THERAPEUTICS SCOTLAND LTD (GB) | 2000-05-24 | — | — | CN | claimed |
| EP-0979291-A1 | METHODS OF PRODUCTION OF AN AMIDATED PEPTIDE THROUGH THE USE OF A FUSION PROTEIN | PPL Therapeutics (Scotland) Limited (GB) | 2000-02-16 | — | — | EP | claimed |
| WO-1998050563-A1 | METHODS OF PRODUCTION OF AN AMIDATED PEPTIDE THROUGH THE USE OF A FUSION PROTEIN | PPL THERAPEUTICS (SCOTLAND) LTD. (GB) | 1998-11-12 | — | — | WO | claimed |
| CN-113710807-B | Microorganisms and methods for producing oxygenates from hexoses | 布拉斯科公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-112601808-B | Microorganism producing eicosapentaenoic acid and process for producing eicosapentaenoic acid | 协和发酵生化株式会社 | 2025-05-02 | — | — | CN | disclosed |
| CN-114126665-B | Gene therapy for yellow spot disease of ocular fundus (ABCA 4) | 马萨诸塞大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-114540456-B | Method for resolution of methyl 2- (benzyloxycarbonylamino) -2- (oxetan-3-yl) acetate | 弈柯莱生物科技(集团)股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-111973738-B | Nucleic acid and recombinant protein co-immune vaccine based on classical swine fever virus gene, preparation method and application | 天康生物制药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20250122515-A1 | COMPOSITIONS AND METHODS FOR INCREASING PLANT GROWTH AND IMPROVING MULTIPLE YIELD-RELATED TRAITS | AFINGEN, INC. (US) | 2025-04-17 | — | — | US | disclosed |
| CN-112740044-B | Method for diagnosis or prognosis of neurological disorders | 阿尔斯特创新有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-114867739-B | Fusion polypeptides comprising GDF15 and a polypeptide domain capable of O-glycosylation | 株式会社LG化学 | 2025-04-08 | — | — | CN | disclosed |
| EP-0884389-A1 | Enzyme participating in C-terminal amidation, and method of preparing same and use thereof | SHISEIDO COMPANY LIMITED (JP) | 1998-12-16 | — | — | EP | disclosed |
| WO-1998050563-A1 | METHODS OF PRODUCTION OF AN AMIDATED PEPTIDE THROUGH THE USE OF A FUSION PROTEIN | PPL THERAPEUTICS (SCOTLAND) LTD. (GB) | 1998-11-12 | — | — | WO | disclosed |
| EP-0438600-B1 | ENZYMES WHICH PARTICIPATE IN C-TERMINAL AMIDATION, AND PRODUCTION AND USE THEREOF | SHISEIDO CO LTD (JP) | 1996-02-07 | — | — | EP | disclosed |
| EP-0666318-A1 | Enzyme participating in c-terminal amidation, and method of preparing same and use thereof | SHISEIDO COMPANY LIMITED (JP) | 1995-08-09 | — | — | EP | disclosed |
| US-5354675-A | Amidation of glycine | SHISEIDO COMPANY LTD. (JP) | 1994-10-11 | — | — | US | disclosed |
| EP-0447547-B1 | C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE | SHISEIDO CO LTD (JP) | 1994-07-27 | — | — | EP | disclosed |
| EP-0447547-A1 | C-TERMINUS AMIDATION ENZYME COMPOSITION, PROCESS FOR ITS PREPARATION AND ITS USE | SHISEIDO COMPANY LIMITED (JP) | 1991-09-25 | — | — | EP | disclosed |
| EP-0438600-A1 | ENZYMES WHICH PARTICIPATE IN C-TERMINAL AMIDATION, AND PRODUCTION AND USE THEREOF | SHISEIDO COMPANY LIMITED (JP) | 1991-07-31 | — | — | EP | disclosed |